Guide your regulatory strategy
Pink Sheet provides you with keen analysis on news and regulatory trends to help you effortlessly navigate biopharma policy and inform your regulatory strategies. Gain insights that can propel your products to market success.
Download key articles from our expert journalists
Our expert journalists at Pink Sheet have selected free article packs to help you gain incisive analysis of current and future policy trends to help inform your regulatory strategies.
Article pack 1: 2025 Predictions
If the first months are any indication, 2025 seems like it might be unpredictable. But the Pink Sheet knows how to look below the surface, however choppy it might be becoming, and help subscribers understand the mechanics of the continuing regulatory processes at health agencies around the world. Below you'll find stories about which drug approvals to expect in the US and Europe, what new policies are under consideration in Japan and India, and how global trade tensions are changing legislative approaches to medicine shortages.
Article pack 2: US FDA and Trump Administration
Donald Trump's second term has already produced many surprising changes throughout the US government, and the FDA is no exception. From an HHS Secretary who questions that value of antidepressants and vaccines to an agency commissioner nominee who embraces compounding, the non-traditional picks have the potential to create significant, disruptive changes. The Pink Sheet helps you keep track of all the meaningful details, not just the enthralling headlines, giving subscribers the tools they need to plan and adapt in this new administration.
What is Pink Sheet?
Since 1939, Citeline’s Pink Sheet has been the leader in providing business-critical insights on pharmaceutical news, and analysis of regulatory policies and trends. Our global team of over 60 journalists track product progress from submission to approval, covering all industry sectors: biosimilars, generics, OTC drugs, and more.
Hear our Pink Sheet journalists from across the globe discuss the important implications of complex biopharma regulations and identify emerging policy directions to help you navigate the every-changing regulatory standards.